Total Funding
72
70
Total FundingGrant raised
Growth Score 72 in past quarter
-2 pts
Heat Score 70 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
160127
NeyroblastGX is a biotechnology company develops theranostic products to treat neurodegenerative and infectious diseases.
- Alexander Michko: Co-Founder, Chief Scientific Officer, and Chief Operating Officer
- Aynun Begum: Co-Founder and CEOPast Role: InnoSense, Senior Scientist
About the Company
NeyroblastGX is a biotechnology company develops theranostic products to treat neurodegenerative and infectious diseases. The company was founded in 2020 and is headquartered in Murrieta, California.
